Sunlenca 4-Tablet Pack

RxCUI: 2625898
RxNorm name: Sunlenca 4-Tablet Pack
Display name: Sunlenca 4-Tablet Pack
Full name: Sunlenca 4-Tablet Pack
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Sunlenca	LENACAPAVIR SODIUM	Gilead Sciences, Inc.	e5652804-29c4-40d7-aeb2-0142ed2a7b5b	2026-03-12	Warnings, Adverse reactions	Exact identifier rxcui: 2625898

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
e5652804-29c4-40d7-aeb2-0142ed2a7b5b	{4 (lenacapavir 300 MG Oral Tablet [Sunlenca]) } Pack [Sunlenca 4-Tablet Pack] [BPCK] · Sunlenca 4-Tablet Pack [PSN] · Sunlenca 4-Tablet Pack [SY]	3	12	These highlights do not include all the information needed to use SUNLENCA safely and effectively. See full prescribing information for SUNLENCA. SUNLENCA ® (lenacapavir) tablets, for oral use SUNLENCA ® (lenacapavir) injection, for subcutaneous use Initial U.S. Approval: 2022	20260312